98 related articles for article (PubMed ID: 9847053)
1. Reverse physiology: discovery of the novel neuropeptide, orphanin FQ/nociceptin.
Civelli O; Nothacker HP; Reinscheid R
Crit Rev Neurobiol; 1998; 12(3):163-76. PubMed ID: 9847053
[TBL] [Abstract][Full Text] [Related]
2. Orphan receptors and the concept of reverse physiology: discovery of the novel neuropeptide orphanin FQ/nociceptin.
Reinscheid RK; Nothacker HP; Civelli O
Results Probl Cell Differ; 1999; 26():193-214. PubMed ID: 10453465
[TBL] [Abstract][Full Text] [Related]
3. Nocistatin: a novel neuropeptide encoded by the gene for the nociceptin/orphanin FQ precursor.
Okuda-Ashitaka E; Ito S
Peptides; 2000 Jul; 21(7):1101-9. PubMed ID: 10998544
[TBL] [Abstract][Full Text] [Related]
4. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor.
Meunier JC
Eur J Pharmacol; 1997 Dec; 340(1):1-15. PubMed ID: 9527501
[TBL] [Abstract][Full Text] [Related]
5. The orphanin FQ/nociceptin (OFQ/N) system.
Civelli O
Results Probl Cell Differ; 2008; 46():1-25. PubMed ID: 18193175
[TBL] [Abstract][Full Text] [Related]
6. Utilizing functional genomics to identify new pain treatments : the example of nociceptin.
Meunier JC
Am J Pharmacogenomics; 2003; 3(2):117-30. PubMed ID: 12749729
[TBL] [Abstract][Full Text] [Related]
7. The History of N/OFQ and the NOP Receptor.
Reinscheid RK; Civelli O
Handb Exp Pharmacol; 2019; 254():3-16. PubMed ID: 30689090
[TBL] [Abstract][Full Text] [Related]
8. Orphanin FQ/nociceptin modulates glutamate- and kainic acid-induced currents in acutely isolated rat spinal dorsal horn neurons.
Shu YS; Zhao ZQ; Li MY; Zhou GM
Neuropeptides; 1998 Dec; 32(6):567-71. PubMed ID: 9920456
[TBL] [Abstract][Full Text] [Related]
9. Possible involvement of endogenous nociceptin/orphanin FQ in the pain-related behavioral responses induced by its own metabolite, nociceptin/orphanin FQ(14-17).
Watanabe H; Mizoguchi H; Orito T; Katsuyama S; Yonezawa A; Watanabe C; Sakurada T; Sakurada S
Peptides; 2007 Mar; 28(3):670-7. PubMed ID: 17196303
[TBL] [Abstract][Full Text] [Related]
10. Primary structure and tissue distribution of the orphanin FQ precursor.
Nothacker HP; Reinscheid RK; Mansour A; Henningsen RA; Ardati A; Monsma FJ; Watson SJ; Civelli O
Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8677-82. PubMed ID: 8710930
[TBL] [Abstract][Full Text] [Related]
11. Nociceptin/orphanin FQ dilates pial arteries by K(ATP) and K(ca) channel activation.
Armstead WM
Brain Res; 1999 Jul; 835(2):315-23. PubMed ID: 10415388
[TBL] [Abstract][Full Text] [Related]
12. Role of altered cyclooxygenase metabolism in impaired cerebrovasodilation to nociceptin/orphanin FQ following brain injury.
Armstead WM
Brain Res Bull; 2000 Dec; 53(6):807-12. PubMed ID: 11179847
[TBL] [Abstract][Full Text] [Related]
13. Role of cAMP and K(+) channel-dependent mechanisms in piglet hypoxic/ischemic impaired nociceptin/orphanin FQ-induced cerebrovasodilation.
Ben-Haim G; Armstead WM
Brain Res; 2000 Nov; 884(1--2):51-8. PubMed ID: 11082486
[TBL] [Abstract][Full Text] [Related]
14. Superoxide generation links nociceptin/orphanin FQ (NOC/oFQ) release to impaired N-methyl-D-aspartate cerebrovasodilation after brain injury.
Kulkarni M; Armstead WM
Stroke; 2000 Aug; 31(8):1990-6. PubMed ID: 10926968
[TBL] [Abstract][Full Text] [Related]
15. Role of nociceptin/orphanin FQ in age-dependent cerebral hemodynamic effects of brain injury.
Armstead WM
J Neurotrauma; 2000 Sep; 17(9):751-64. PubMed ID: 11011815
[TBL] [Abstract][Full Text] [Related]
16. Nociceptin/orphanin FQ alters prostaglandin cerebrovascular action following brain injury.
Ford J; Armstead WM
J Neurotrauma; 2004 Feb; 21(2):187-93. PubMed ID: 15000759
[TBL] [Abstract][Full Text] [Related]
17. Effect of intrathecal nocistatin on the formalin-induced pain in mice versus that of nociceptin/orphanin FQ.
Nakano H; Minami T; Abe K; Arai T; Tokumura M; Ibii N; Okuda-Ashitaka E; Mori H; Ito S
J Pharmacol Exp Ther; 2000 Jan; 292(1):331-6. PubMed ID: 10604967
[TBL] [Abstract][Full Text] [Related]
18. Age-dependent NOC/oFQ contribution to impaired hypotensive cerebral hemodynamics after brain injury.
Armstead WM
J Neurotrauma; 2002 Oct; 19(10):1193-202. PubMed ID: 12427328
[TBL] [Abstract][Full Text] [Related]
19. NOC/oFQ contributes to hypoxic-ischemic impairment of N-methyl-D-aspartate-induced cerebral vasodilation.
Armstead WM
Brain Res; 2000 Jun; 868(1):48-55. PubMed ID: 10841887
[TBL] [Abstract][Full Text] [Related]
20. NOC/oFQ activates PKC and generates superoxide to impair hypotensive cerebrovasodilation after hypoxia/ischemia.
Armstead W
Med Sci Monit; 2002 Jan; 8(1):BR8-BR14. PubMed ID: 11782666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
